Login
Toggle navigation
Videos
Categories
Trending
SOSVs program for startups with a hardware element|Cyril Ebersweiler,General Partner,HAX
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
General Partner at SOSV and the founder/MD of HAX.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Values and Success: Building Legacy and Making a Difference at M&T
00:10:00
Amy Nap: Journey to Private Equity Leadership at Corsair Capital
00:10:00
Principal Financial Group: Nurturing Health, Wealth, and Community | Dan Houston, CEO, Principal Financial Group.
00:10:00
uses tech to disrupt existing markets or create entirely new ones|Kevin Zhang,Partner,Bain Capital Ventures
00:10:00
Resolving Cross-Border Transfer Pricing Disputes: Insights from Clark Armitage on the 'GILTI Conscience' Podcast | John Slate - Founder of Skadden
00:10:00
VD Niklas Stenberg Presents the Company | NIKLAS STENBERG - President, Chief Executive Officer of Addtech
00:10:00
Supporting Mental Health in Mining: High-Tech Drilling's Commitment
00:10:00
Coda Minerals' Development Progress and Future Plans
00:10:00
In this video, CEO Tobias Hartmann and CFO Dirk Schmelzer provide insights into Scout24's preliminary results for 2023.
00:10:00
Mustang Resources Unveils Promising Ruby and Graphite Projects in Mozambique at One-to-One Conference
00:10:00
Nuinsco Resources Limited has had 50 years of exploration success and is a growth oriented, multi-commodity mineral exploration|Paul Jones,CEO,Nuinsco Resources Limited
00:10:00
MJB Financial Planning: Balancing Spending and Savings for Retirees and Young Couples | Matt Buckwalter - PRINCIPAL of MJB Financial Planning, LLC